Current techniques to accurately measure anti-retinal autoantibodies
- 12 March 2020
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Ophthalmology
- Vol. 15 (2) , 111-118
Abstract
Introduction: Autoimmune retinopathy (AR) is a sight-threating retinal disorder that is mediated by autoantibodies (AAbs) against retinal proteins. The visual paraneoplastic syndromes, including cancer-associated retinopathy (CAR) and melanoma-associated retinopathy (MAR), are mediated by anti-retinal AAbs. A number of immunochemical techniques have been used to detect serum anti-retinal autoantibodies in patients to help with autoimmune diagnosis. Area covered: We review techniques used for serum autoantibody evaluation in patients with suspected autoimmune retinopathy. Expert opinion: Detection of serum AAbs has served as the standard diagnostic tool for autoimmune retinopathies and for management of retinal disorders. An identification of anti-retinal autoantibody or multiple autoantibodies can be useful for not only for diagnosis of autoimmune retinopathies but also for management of retinal disorders. We propose that the line-blotting technique used in conjunction with immunohistochemistry are the best and most reliable assays for detection of serum anti-retinal AAb in the context of clinical history and findings. Clinician should recognize that the majority of antigenic targets identified to date in retinal autoimmunity are ubiquitously expressed proteins (e.g. enolase), which may be difficult to reconcile with the specific patterns of retinal damage observed in CAR, MAR, or AR.Keywords
This publication has 44 references indexed in Scilit:
- Detection of autoantibodies against heat shock proteins and collapsin response mediator proteins in autoimmune retinopathyBMC Ophthalmology, 2013
- Natural IgG Autoantibodies Are Abundant and Ubiquitous in Human Sera, and Their Number Is Influenced By Age, Gender, and DiseasePLOS ONE, 2013
- New insights into autoantibody profiles from immune privileged sites in the eye: A glaucoma studyBrain, Behavior, and Immunity, 2012
- Diversity in autoimmunity against retinal, neuronal, and axonal antigens in acquired neuro-retinopathyJournal of Ophthalmic Inflammation and Infection, 2011
- Molecular biomarkers for autoimmune retinopathies: Significance of anti-transducin-alpha autoantibodiesExperimental and Molecular Pathology, 2009
- Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathyAutoimmunity Reviews, 2009
- Autoantibodies to p75/LEDGF, a cell survival factor, found in patients with atypical retinal degenerationJournal of Autoimmunity, 2006
- Antigen arrays for antibody profilingCurrent Opinion in Chemical Biology, 2006
- SEREX identification of new tumor antigens linked to melanoma-associated retinopathyInternational Journal of Cancer, 2004
- Cancer-Associated Retinopathy (CAR Syndrome) with Antibodies Reacting with Retinal, Optic-Nerve, and Cancer CellsNew England Journal of Medicine, 1989